BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-11@pharmaconomics
DTSTAMP:20260707T005946Z
DTSTART;VALUE=DATE:20261030
DTEND;VALUE=DATE:20261031
SUMMARY:INO PDUFA — INO-3107
DESCRIPTION:The FDA's approval decision on INO-3107 for Recurrent Respiratory Papillomatosis (RRP) is due Oct 30\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1055726/000105572626000009/ino-123125x8kex991.htm\n\nTrack it: https://www.pharmaconomics.com/e/11
URL:https://www.pharmaconomics.com/e/11
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:INO catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR